首页> 外文期刊>Journal of affective disorders >Treatment and outcome of antidepressant treatment-associated hypomania in unipolar major depression: A 3-year follow-up study
【24h】

Treatment and outcome of antidepressant treatment-associated hypomania in unipolar major depression: A 3-year follow-up study

机译:单相严重抑郁症的抗抑郁治疗相关性躁狂的治疗和结果:一项为期三年的随访研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: The main aim of this study was to propose a standardized acute and maintenance/ continuation treatment protocol for acute antidepressant treatment-associated hypomania (AAH) in major unipolar depression. The second objective was to describe outcomes at three-year follow-up in a cohort of patients with AAH who had been included in this standardized therapeutic protocol. Methods: The study consisted of two distinct prospective phases: a 1-year follow-up first phase in which all consecutive patients with a diagnosis of moderate/severe unipolar depressive disorder received acute and continuation/maintenance antidepressant treatment; and a second phase, in which patients who had suffered AAH during the first phase were admitted to a 3-year follow-up with the authors-designed standardized acute and continuation/maintenance treatment protocol.Results: In our patient sample, the reintroduction of antidepressant treatment according to the proposed protocol was not accompanied by new AAH episodes following 11-36 months of pharmacological antidepressant treatment. The second notable result was that no subject presented manic episodes or spontaneous hypomania (once antidepressant maintenance treatment had finished) during three years of follow-up.Limitations: We should be cautious when generalizing these results to patients with mild major depressive episode or other type of unipolar affective disorder.Conclusions: Based on these results, we should not refuse the prescription of antidepressant drugs to patients with unipolar depression and subsequent AAH. The treatment protocol which we describe in this study can serve as a basis for future studies and, in anticipation of future consensus, as a practical proposal for clinical psychiatrists.
机译:背景:本研究的主要目的是为重症单相抑郁症的急性抗抑郁治疗相关的轻躁狂(AAH)提出一种标准化的急性和维持/持续治疗方案。第二个目标是描述该标准化治疗方案中包括的一组AAH患者的三年随访结果。方法:该研究包括两个不同的前瞻性阶段:一个为期1年的随访第一阶段,在该阶段中,所有诊断为中/重度单相抑郁症的连续患者均接受急性和持续/维持性抗抑郁治疗。第二阶段,在第一阶段中患有AAH的患者接受了作者设计的标准化急性和持续/维持治疗方案的3年随访。结果:在我们的患者样本中,再次引入了在11-36个月的药物抗抑郁药治疗后,根据拟议方案进行的抗抑郁药治疗未伴有新的AAH发作。第二个值得注意的结果是在三年的随访中没有受试者出现躁狂发作或自发性躁狂(一旦完成抗抑郁药物维持治疗)。局限性:将这些结果推广到轻度重度抑郁发作或其他类型的患者时应谨慎结论:基于这些结果,我们不应该拒绝对单相抑郁症及随后的AAH患者使用抗抑郁药。我们在本研究中描述的治疗方案可以作为未来研究的基础,并且在期待未来达成共识的情况下,可以作为临床精神科医生的实用建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号